231 related articles for article (PubMed ID: 27046088)
1. Effect of different synthetic membranes on laboratory parameters and survival in chronic haemodialysis patients.
Kreusser W; Reiermann S; Vogelbusch G; Bartual J; Schulze-Lohoff E
NDT Plus; 2010 May; 3(Suppl 1):i12-i19. PubMed ID: 27046088
[No Abstract] [Full Text] [Related]
2. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
[TBL] [Abstract][Full Text] [Related]
3. High-volume online haemodiafiltration improves erythropoiesis-stimulating agent (ESA) resistance in comparison with low-flux bicarbonate dialysis: results of the REDERT study.
Panichi V; Scatena A; Rosati A; Giusti R; Ferro G; Malagnino E; Capitanini A; Piluso A; Conti P; Bernabini G; Migliori M; Caiani D; Tetta C; Casani A; Betti G; Pizzarelli F
Nephrol Dial Transplant; 2015 Apr; 30(4):682-9. PubMed ID: 25385719
[TBL] [Abstract][Full Text] [Related]
4. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role?
Aucella F; Vigilante M; Gesuete A; Maruccio G; Specchio A; Gesualdo L
Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v8-12. PubMed ID: 17586845
[TBL] [Abstract][Full Text] [Related]
5. Effect of high-flux dialysis on the anaemia of haemodialysis patients.
Locatelli F; Andrulli S; Pecchini F; Pedrini L; Agliata S; Lucchi L; Farina M; La Milia V; Grassi C; Borghi M; Redaelli B; Conte F; Ratto G; Cabiddu G; Grossi C; Modenese R
Nephrol Dial Transplant; 2000 Sep; 15(9):1399-409. PubMed ID: 10978398
[TBL] [Abstract][Full Text] [Related]
6. Differential activation of monocytes in haemodialysis patients exposed to different types of membranes.
Blumenstein M; Ziegler-Heitbrock HW; Schiller B; Schmidt B; Ward RA; Gurland HJ
Scand J Immunol; 1990 Feb; 31(2):183-90. PubMed ID: 2309101
[TBL] [Abstract][Full Text] [Related]
7. Enhanced long-term reduction of plasma leptin concentrations by super-flux polysulfone dialysers.
van Tellingen A; Grooteman MP; Schoorl M; ter Wee PM; Bartels PC; Schoorl M; van der Ploeg T; Nubé MJ
Nephrol Dial Transplant; 2004 May; 19(5):1198-203. PubMed ID: 14993491
[TBL] [Abstract][Full Text] [Related]
8. Effect of dialyzer membrane materials on survival in chronic hemodialysis patients: Results from the annual survey of the Japanese Nationwide Dialysis Registry.
Abe M; Hamano T; Wada A; Nakai S; Masakane I;
PLoS One; 2017; 12(9):e0184424. PubMed ID: 28910324
[TBL] [Abstract][Full Text] [Related]
9. Effect of acetate-free biofiltration on the anaemia of haemodialysis patients: a prospective cross-over study.
Basile C; Giordano R; Montanaro A; De Maio PD; De Padova FD; Marangi AL; Semeraro A
Nephrol Dial Transplant; 2001 Sep; 16(9):1914-9. PubMed ID: 11522879
[TBL] [Abstract][Full Text] [Related]
10. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
Stojimirović B; Grujić-Adanja G
Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of plasma insulin and C-peptide levels with 3 different high-flux dialyzers in diabetic patients on hemodialysis.
Abe M; Okada K; Maruyama T; Inoshita A; Ikeda K; Uto E; Kikuchi F; Matsumoto K
Int J Artif Organs; 2008 Oct; 31(10):898-904. PubMed ID: 19009508
[TBL] [Abstract][Full Text] [Related]
12. Effect of N-acetylcysteine on residual renal function in chronic haemodialysis patients treated with high-flux synthetic dialysis membranes: a pilot study.
Feldman L; Abu Hamad R; Efrati S; Ashker A; Beberashvili I; Shani M
ISRN Nephrol; 2013; 2013():636208. PubMed ID: 24977134
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study.
Gastaldello K; Melot C; Kahn RJ; Vanherweghem JL; Vincent JL; Tielemans C
Nephrol Dial Transplant; 2000 Feb; 15(2):224-30. PubMed ID: 10648669
[TBL] [Abstract][Full Text] [Related]
14. Synthetically modified cellulose: an alternative to synthetic membranes for use in haemodialysis?
Hoenich NA; Woffindin C; Stamp S; Roberts SJ; Turnbull J
Biomaterials; 1997 Oct; 18(19):1299-303. PubMed ID: 9307219
[TBL] [Abstract][Full Text] [Related]
15. Anti-Inflammatory Approach in Chronic Dialysis Patients with SARS-CoV-2: ATA or PMMA Dialyzers?
Donati G; Gasperoni L; Napoli M; Scrivo A; Zappulo F; Abenavoli C; Hu L; Angelini A; Di Nunzio M; Tringali E; Cingolani A; Marchegiani BC; Rigotti A; La Manna G
Blood Purif; 2023; 52(2):210-218. PubMed ID: 36323242
[TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations of AB-amyloidosis: effects of biocompatibility and flux.
Schiffl H; Fischer R; Lang SM; Mangel E
Nephrol Dial Transplant; 2000 Jun; 15(6):840-5. PubMed ID: 10831638
[TBL] [Abstract][Full Text] [Related]
17. Improved outcome for haemodialysis patients treated with high-flux membranes.
Woods HF; Nandakumar M
Nephrol Dial Transplant; 2000; 15 Suppl 1():36-42. PubMed ID: 10737165
[TBL] [Abstract][Full Text] [Related]
18. High-Performance Membrane Dialyzers and Mortality in Hemodialysis Patients: A 2-Year Cohort Study from the Annual Survey of the Japanese Renal Data Registry.
Abe M; Hamano T; Wada A; Nakai S; Masakane I
Am J Nephrol; 2017; 46(1):82-92. PubMed ID: 28675885
[TBL] [Abstract][Full Text] [Related]
19. Amino acid and albumin losses during hemodialysis.
Ikizler TA; Flakoll PJ; Parker RA; Hakim RM
Kidney Int; 1994 Sep; 46(3):830-7. PubMed ID: 7996804
[TBL] [Abstract][Full Text] [Related]
20. Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients.
Movilli E; Cancarini GC; Zani R; Camerini C; Sandrini M; Maiorca R
Nephrol Dial Transplant; 2001 Jan; 16(1):111-4. PubMed ID: 11209002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
